期刊文献+

双丙戊酸钠与普萘洛尔预防偏头痛发作的疗效观察 被引量:6

下载PDF
导出
摘要 目的:观察双丙戊酸钠、普萘洛尔对偏头痛发作的预防作用。方法:将83例偏头痛患者随机分为双丙戊酸钠组(42例,A组)、普萘洛尔组(41例,B组),治疗2个月后对上述两组预防效果进行比较。结果:A组与B组总有效率分别为73.81%及68.30%,预防疗效无显著差异(P>0.05),A组副作用更少。结论:双丙戊酸钠、普萘洛尔对偏头痛发作均有较好的预防作用,双丙戊酸钠应用更安全。
机构地区 解放军第
出处 《实用医学杂志》 CAS 北大核心 2009年第11期1866-1867,共2页 The Journal of Practical Medicine
  • 相关文献

参考文献6

  • 1Silberstein S D, Goadsby P J, Lipton R I. Management of migraine: an algorithmic approach [J]. Neurol,2000,55(Suppl 2) : s46.
  • 2乔向阳.头痛疾患的分类和诊断(指南)[J].继续医学教育,2005,19(3):74-78. 被引量:29
  • 3金雨来,黄流清.偏头痛预防药物研究进展[J].世界临床药物,2006,27(2):105-109. 被引量:6
  • 4匡培根.偏头痛[J].中国疼痛医学杂志,2002,8(2):111-115. 被引量:57
  • 5Mathew N T, Saper J R, Silberstein S D, et al. Migraine prophylaxis with divalproex [J]. Arch Neurol. 1995 ,52(3):281- 286.
  • 6Chronicle E, Mulleners W. Anticonvulsant drugs for migraine prophylaxis [ J]. Cochrane Database Syst Rev, 2004, (3) : CD003226.

二级参考文献4

  • 1F. Moschiano,G. Allais,L. Grazzi,S. Usai,C. Benedetto,D. D’Amico,M. Roncolato,G. Bussone. Naratriptan in the short-term prophylaxis of pure menstrual migraine[J] 2005,Neurological Sciences(2):s162~s166
  • 2F. Frediani. Anticonvulsant drugs in primary headaches prophylaxis[J] 2004,Neurological Sciences(3):s161~s166
  • 3Prof.Dr. Hans-Christoph Diener,P. Tfelt-Hansen MD, PhD,C. Dahl?f MD, PhD,M. J. A. Láinez MD, PhD,G. Sandrini MD,Sh.-J. Wang MD,W. Neto MD,U. Vijapurkar PhD,A. Doyle MD,D. Jacobs MD. Topiramate in migraine prophylaxis[J] 2004,Journal of Neurology(8):943~950
  • 4K. Vahedi,P. Taupin,R. Djomby,M. El-Amrani,G. Lutz,V. Filipetti,P. Landais,H. Massiou,M. G. Bousser. Efficacy and tolerability of acetazolamide in migraine prophylaxis: A randomised placebo-controlled trial[J] 2002,Journal of Neurology(2):206~211

共引文献88

同被引文献39

  • 1徐思秦.太极通天液治疗头痛157例临床疗效观察[J].中国医药导报,2006,3(23). 被引量:4
  • 2王爱菊.黛立新联合尼莫地平治疗偏头痛疗效观察[J].实用医学杂志,2006,22(10):1204-1204. 被引量:6
  • 3刘太平.太极通天液配合西比灵治疗偏头痛的疗效观察[J].现代医药卫生,2007,23(2):243-243. 被引量:1
  • 4中村友紀,徐万鹏.紧张型头痛的分类和诊断标准[J].日本医学介绍,2007,28(1):8-11. 被引量:32
  • 5Lars Edvinsson. Treatment of migraine attacks based on the interaction with the trigemino-cerebrovascular system. J Headache Pain,2008, 9:5-12.
  • 6D' amico D, Grazzi L, Usai S, et al. Topiramate in migraine prophylaxis. Neural Sci, 2005, 26(Suppl. 2) : s130-133.
  • 7Karakurum B, Soylu O, Karatas M, et al. Personality, depression, and anxiety as risk factors for chronic migraine [J]. Int J Neurosci, 2004, 114(11): 1391-1399.
  • 8McWilliams L A, Goodwin R D, Cox B J, et al. Depression and anxiety associated with three pain conditions: results from a nationally representative sample [J].Pain, 2004, 111(1- 2) : 77-83.
  • 9Narin S O, Pinar L, Erbas D, et al. The effects of exercise and exercise-related changes in blood nitric oxide level on migraine headache [J]. Clin Rehabil, 2003, 17(6): 624-630.
  • 10Jette N, Patten S, Williams J, et al. Comorbidity of migraine and psychiatric disorders-A National Population-Based Study [J]. Headache, 2008, 48(4): 501-516.

引证文献6

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部